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Abstract
Background: The periodontal disease is caused by a set of inflammatory disorders characterized by periodontal
pocket formation that lead to tooth loss if untreated. The proteomic profile and related molecular conditions of
pocket tissue in periodontally-affected patients are not reported in literature. To characterize the proteomic profile
of periodontally-affected patients, their interproximal periodontal pocket tissue was compared with that of
periodontally-healthy patients. Pocket-associated and healthy tissue samples, harvested during surgical therapy,
were treated to extract the protein content. Tissues were always collected at sites where no periodontal-pathogenic
bacteria were detectable. Proteins were separated using two-dimensional gel electrophoresis and identified by
liquid chromatography/mass spectrometry. After identification, four proteins were selected for subsequent Western
Blot quantitation both in pathological and healty tissues.
Results: A significant unbalance in protein expression between healthy and pathological sites was recorded.
Thirty-two protein spots were overall identified, and four proteins (S100A9, HSPB1, LEG7 and 14-3-3) were selected for
Western blot analysis of both periodontally-affected and healthy patients. The four selected proteins resulted
over-expressed in periodontal pocket tissue when compared with the corresponding tissue of periodontally-healthy
patients. The results of Western blot analysis are congruent with the defensive and the regenerative reaction of injured
periodontal tissues.
Conclusions: The proteomic analysis was performed for the first time directly on periodontal pocket tissue. The
proteomic network highlighted in this study enhances the understanding of periodontal disease pathogenesis
necessary for specific therapeutic strategies setting.
Keywords: Proteome analysis, Periodontitis, Two-dimensional gel electrophoresis, Protein identification, LC-MS/
MS
Background
The periodontal ligament surrounds the tooth root, con-
nects it to its bony socket constituting a fibrous joint
named gomphosis. It contains a large variety of cells and
tissues, including immune and stem cells [1, 2]. The
periodontitis is a set of inflammatory disorders charac-
terized by gingival and periodontal inflammation,
periodontal attachment loss, and alveolar bone resorp-
tion, following to periodontal pocket development [3–6].
The periodontal-pathogenic microbiome ecosystems
are the most proven risk factor of periodontal disease.
Pathogens adhere to and grow on the tooth surfaces,
and the inappropriate inflammatory response causes the
loss of periodontal attachment and alveolar bone, giving
rise to the periodontal pocket, the typical expression of
periodontitis, that lead to tooth loss, if untreated.
Periodontitis diagnosis is based on clinical assessment
only, inspecting the soft gum tissues around the teeth
with a probe (i.e. a clinical examination) in order to
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detect interproximal attach level-loss and periodontal
pocket depth, in the absence of a reliable pathogenic
check based on appropriate interpretation of inflamma-
tion [5, 7, 8].
Recently, the role of cytokines and other protein medi-
ators of inflammation erupted in all their importance
[9]. A modern pathogenetic model incorporating gene,
protein, and metabolite data into dynamic biological
processes is based on a multilevel framework that in-
clude disease-initiating and -resolving mechanisms that
are regulated by innate and environmental factors [10].
Now, we can describe more effectively the basic elements
of a new model of pathogenesis using emerging genomic,
proteomic, and metabolomic techniques [10, 11]. Recent
progress in tissue isolation, protein separation, quantifica-
tion and sequence analysis utilizing novel proteomic tech-
niques promises to bring periodontal physiology and
pathology into a new era. A list of inflammation-involved
proteins, cytokines, matrix expression and cellular proteins
in the periodontal tissues is not currently available. Studies
on periodontal diseases utilizing proteomic analysis have
been performed on saliva or crevicular fluid samples
[12–15], peripheral blood [16–18] or periodontal
plaque samples [19], but not on the pathologic tissue of
the periodontal pocket, which is the key lesion of the
periodontal disease.
To overcome the lack of data, studies assessing the
proteomic profile of periodontal pocket tissue and evalu-
ating the molecular characteristics of the periodontally
affected patient, are needed.
The aim of this work was to compare the proteomic
profile of the pathologic interproximal gingival pocket
tissue with that of interproximal gingival healthy tissue,
obtained from sites where no periodontal-pathogenic
bacteria were detectable.
Results
Fifteen subjects (T, test group), 3 males and 12 females,
ranging in age from 20 to 64 years, average 42.82 ± 13.2
(m ± SD), and fifteen periodontally healthy subjects (C, con-
trol group), 6 males and 9 females, ranging in age from 19
to 60 years, average 44.90 ± 11.55, fulfilled study require-
ments (Table 1). T subjects underwent to the periodontal
resective treatment, while C subjects underwent to the
crown lengthening surgical treatment. All subjects followed
a stringent post-operative supportive care program and
achieved satisfactory clinical outcomes.
2DE (Two-dimensional gel electrophoresis) and LC-MS/
MS (Liquid Chromatography-tandem mass spectrometry)
analysis were performed for T and C gingival tissue sam-
ples. Figure 1 shows representative 2DE gel images of T
and C tissues and the 32 protein spots identified. Pri-
mary accession number, entry name of UniProt data-
base, MW (Molecular Weight), highest score, matches,
sequences and emPAI (Exponentially Modified Protein
Abundance Index) for each identified protein are re-
ported in Table 2. Web-based bioinformatics tools
(iPROClass and CateGOrize) were employed to investi-
gate all potential localizations, molecular functions and
biological processes of the identified proteins (Fig. 2).
Intracellular proteins represented the most abundant
population (77.3 %). Among them, 18.6 % of protein
annotations were recognized as belonging to cytoplasm,
5.6 % to cytoskeleton, and nucleus 8.8 %. Other protein
annotations were recognized, with smaller fractions, as
belonging to other cellular component such as mito-
chondrion, vacuole or plasma membrane (Fig. 2a). The
reported function of the identified proteins suggests
that they are mainly involved in binding (46.8 %), pro-
tein binding (15.3 %), and catalytic activity (8.8 %).
Other relevant functions are nucleic acid binding
(6.6 %), enzyme regulator activity (4.4 %), structural
molecule activity (4.4 %), antioxidant activity, lipid
binding (2.9 %), nucleotide binding (2.2 %) and trans-
ferase activity (1.5 %) (Fig. 2b). In summary, the identi-
fied proteins are mainly involved in metabolism
(31,9 %), transport (13,3 %) and cell organization and
biogenesis (12 %) (Fig. 2c).
PDQuest spot intensity quantification identified four pro-
teins expressed only in the pathological tissue, as shown in
Fig. 3, that were selected for subsequent Western blot ana-
lysis in both T and C subjects.
Table 1 Systemic and specific adopted inclusion criteria
Systemic Inclusion Criteria Local Inclusion Criteria
Absence of relevant medical conditions: Medical history of good health (particularly
ruling out bone disease, uncontrolled or poorly controlled diabetes, unstable or
life-threatening conditions, or requiring antibiotic prophylaxis were excluded).
Defect anatomy:
Presence of at least one intrabony defect in patient with
periodontal disease.
Excessive gingival display or gingival margin asymmetries required
a surgical correction in periodontally-healthy patients
Smoking status: Non-smokers and without a story of alcohol abuse. Good oral hygiene: full-mouth plaque score (FMPS) ≤20 %
Compliance: only patients showing high levels of compliance (as assessed during
the cause-related phase of therapy) were selected.
Low level of residual infection: full-mouth bleeding score (FMBS)
≤20 %.
Pregnancy or lactation and underage were excluded. Endodontic status: Experimental teeth had to be vital or properly
treated with root canal therapy.
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Representative Western blot images for S100A9,
HSPB1, 14-3-3 and LEG7 and β-actin are reported in
Fig. 4. Densitometric analyses of Western blot images,
normalized to β-actin expression (Fig. 5) confirmed that
in C specimens (control tissue), the S100A9, 14-3-3,
LEG7 and HSPB1 proteins were not expressed. In patho-
logical tissue (T specimens), the intensity signal for
S100A9 and HSPB1 was much higher than the intensity
signal of 14-3-3 and LEG7 proteins.
Discussion
Very little is know on the proteomic analysis of the peri-
odontal pocket tissue [6]. Most proteomic studies have
been performed on gingival crevicular fluid, saliva or
blood serum, since the non-invasive nature of the collec-
tion and availability [20–23]. These studies assume the
existence of a direct correlation between the periodontal
disease and the biological source to be tested, however
there is no direct evidence supporting such assumption.
Actually, the periodontal pocket is certainly the
anatomo-pathological lesion signifying for an active peri-
odontal disease [7, 8]. Therefore, the periodontal pocket
tissue is the only biologic material in which proteomic
analysis enables the correct molecular assessment of the
periodontal disease. Despite genomic, transcriptomic
and proteomic research performed up to now, there are
no available biomarkers for periodontitis diagnosis,
prognosis and treatment indication giving assistance to
the clinician in the disease management. Excluding the
studies performed on biologic material different from
periodontal tissue, some genomic studies carried out on
the gingival tissue showed an association of specific gene
polymorphism to periodontitis [24–26].
In our study, proteomics was applied to comparatively
analyze the protein content of interproximal tissues of
healthy and periodontally affected patients, with the aim
to identify differentially expressed proteins. The pres-
ence of common periodontopathogenic bacteria was ex-
cluded, focusing on disease progression related to the
prevailing stimulus, avoiding in this way the possible
straining effect caused by periodontopathogenic bacteria
on the local protein content. In this way we could dis-
criminate the individual component of the periodontal
disease.
The differential expression level observed in 2DE, in
pathological and healthy tissues, of 4 proteins, S100A9,
HSPB1, LEG7 and 14-3-3, was confirmed by Western
blot analysis.
S100A9, is a calcium- or zinc-binding protein involved
in the regulation of inflammatory processes and immune
response [27], predominantly found as calprotectin
(S100A8/S100A9 etherodimer). S100A9 contribute to
homeostatic processes that include cytoskeletal rear-
rangements during trans-endothelial migration of pro-
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Fig. 1 2DE gel of Control and Test tissues. Proteins identified by LC-MS/MS are indicated by Entry name (ID) and pointed by arrows. Control = healthy
gingival tissue, Test = periodontal pocket tissues
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inflammatory phagocytes, binding to receptors as Toll-
like receptor 4 and receptor for advanced glycation end
products, antimicrobial, oxidant-scavenging and
apoptosis-inducing activities [28, 29]. In extracellular
fluid, increased levels of S100A9/S100A8 etherodimer
were reported in numerous inflammation-associated
conditions, such as rheumatoid arthritis, Crohn’s
Disease, colorectal cancer and in GCF (Gingival Crevicular
Fluid) of patients suffering from gingivitis and periodontitis
[30, 31]. The S100A9/S100A8 etherodimer concentration
was correlated with periodontal markers of inflammation
such as pocket probing depth or gingival bleeding [32, 33].
Table 2 List of identified proteins in periodontal pocket tissues
AC Numbera) Entry Nameb) Score Mass (kDa) pI Matchesc) Significant
matches
Sequencesd) Significant
sequences
emPAIe) Description
P02768 ALBU_HUMAN 5019 71317 5.92 435 310 43 40 6.59 Serum albumin
P13646 K1C13_HUMAN 2745 49900 4.91 247 140 31 23 4.99 Keratin, type I cytoskeletal 13
P19013 K2C4_HUMAN 1509 57649 6.25 176 101 25 18 2.21 Keratin, type II cytoskeletal 4
Q01469 FABP5_HUMAN 1050 15497 6.60 95 44 21 12 16.08 Fatty acid-binding protein,
epidermal
P01834 IGKC_HUMAN 829 11773 5.58 65 51 5 5 6.66 Ig kappa chain C region
P01834 IGKC_HUMAN 771 11773 5.58 62 47 5 5 5.11 Ig kappa chain C region
P06733 ENOA_HUMAN 757 47481 7.01 67 40 22 15 2.43 Alpha-enolase
P31947 1433S_HUMAN 592 27871 4.68 88 49 19 12 3.12 14-3-3 protein sigma
P08727 K1C19_HUMAN 492 44079 5.05 51 27 14 9 0.78 Keratin, type I cytoskeletal 19
P00915 CAH1_HUMAN 403 28909 6.59 46 29 8 6 1.39 Carbonic anhydrase 1
P07355 ANXA2_HUMAN 382 38808 7.57 31 17 12 7 0.74 Annexin A2
P04406 G3P_HUMAN 377 36201 5.43 20 19 5 4 0.69 Glyceraldehyde-3-phosphate
dehydrogenase
Q06830 PRDX1_HUMAN 358 22324 8.27 53 26 13 6 1.10 Peroxiredoxin-1
P63104 1433Z_HUMAN 317 27899 4.7 43 17 14 8 2.31 14-3-3 protein zeta/delta
P67936 TPM4_HUMAN 282 28619 4.67 51 27 19 14 3.41 Tropomyosin alpha-4 chain
P02647 APOA1_HUMAN 260 30759 5.56 45 22 16 9 5.56 Apolipoprotein A-I
P32119 PRDX2_HUMAN 223 22049 5.66 24 15 9 8 2.10 Peroxiredoxin-2
P06702 S10A9_HUMAN 217 13291 5.71 42 20 8 4 2.94 Protein S100-A9
P47929 LEG7_HUMAN 207 15123 7.03 59 22 7 7 3.74 Galectin-7
P62937 PPIA_HUMAN 197 18229 7.68 11 7 4 3 0.97 Peptidyl-prolyl cis-trans
isomerase A
P02675 FIBB_HUMAN 183 55892 8.54 5 3 5 3 0.27 Fibrinogen beta chain
P04792 HSPB1_HUMAN 177 22826 5.98 27 10 9 5 0.83 Heat shock protein beta-1
P60709 ACTB_HUMAN 144 42052 5.29 55 23 13 7 0.67 Actin, cytoplasmic 1
P04792 HSPB1_HUMAN 132 22826 5.98 38 14 7 3 0.69 Heat shock protein beta-1
P09211 GSTP1_HUMAN 124 23569 5.43 6 3 2 1 0.30 Glutathione S-transferase P
P60174 TPIS_HUMAN 118 31057 6.45 17 9 5 4 0.43 Triosephosphate isomerase
P30043 BLVRB_HUMAN 118 22219 7.13 9 5 3 1 0.28 Flavin reductase (NADPH)
P36952 SPB5_HUMAN 80 42530 5.72 4 3 2 2 0.16 Serpin B5
Q9BYX7 ACTBM_HUMAN 76 41989 5.29 2 2 2 2 0.24 Putative beta-actin-like
protein 3
P08670 VIME_HUMAN 71 53676 5.06 37 5 10 3 0.20 Vimentin
P06702 S10A9_HUMAN 54 13291 5.71 17 6 3 2 0.83 Protein S100-A9
P00918 CAH2_HUMAN 53 29285 8.15 12 6 3 2 0.33 Carbonic anhydrase 2
a)Primary accession number from UniProt database
b)Primary entry name from UniProt database
c)The number of peptides that matched the identified proteins
d)The number of distinct sequences
e)Exponentially Modified Protein Abundance Index
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S100A9 was identified in saliva and proposed as a potential
marker to monitor the progression of orthodontic treat-
ment [33]. However, the Authors showed an apparent
down-regulation of S100A9 protein, suggesting that this
protein could not be involved during bone resorption in
orthodontic tooth movement but it was implicated in in-
flammation. This protein also promotes apoptosis and
modulate the inflammatory response in periodontal liga-
ment cells so its down-regulation could suggest a suppres-
sion of inflammation [33, 34].
HSPB1 synthesis increases in response to a variety of
stresses (e.g. elevated temperatures, heavy metals, toxins,
oxidants, bacterial and viral infections) in order to
minimize the deleterious consequences of these stimuli
and provide the maximal cytoprotective effect [35–39].
In oral tissues, HSPB1 was localized in fibroblasts, odon-
toblasts, osteoblasts, epithelial cells, endothelial cells of
the vascular wall of the dental pulp, and cells of the peri-
odontal ligament [37, 40]. HSPB1 is also a procollagen-
binding protein involved in the biosynthesis of type I
collagen and major bone extracellular matrix [41].
HSPB1 could be a potential target for the periodontal
regeneration process related to cell migration, cytoskel-
eton maintaining and tissue preservation, also through
the modulation of the immune system, and its under-
expression induces differentiation abortion, in relation
to cell death by apoptosis [40].
Galectin-7 (LEG7) is associated with epithelial cell mi-
gration and accelerates the re-epithelialization of
wounds. In particular, LEG7 expression contributes to
the tissue remodeling processes following tissue damage
that involves apoptotic cell death [42]; a defective LEG7
expression could impair the healing processes. LEG7
could function in the maintenance of the normal pheno-
type of epithelial cell and is activated by a wide range of
cellular stresses including UV and γ irradiation. LEG7
protects cell from death by functioning inside the cell
and interacting with intracellular proteins. Finally, LEG7
belongs to a protein family promoting healing processes
and favor immune responses [43]. HSPB1 and LEG7
would seem to be part of a protein network that play an
important role in controlling cell and tissue damage, in
moderating the inflammation and destructive immune
response. The lack of the previously described multi-
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Fig. 2 Pie charts describe the distribution of protein localization (a), main biological functions (b) and biological processes (c) of identified
proteins of periodontal pocket tissue by GO analysis
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protective effect of these proteins, particularly in the
presence of inflammation, hinders cells to protect them-
selves against the cytotoxicity of inflammatory mediators
[44], increases their susceptibility to necrotic cell death
[45] and probably does not allow an efficient immune
response against the noxa [46].
The 14-3-3 protein sigma and zeta/delta are regulatory
phosphorserine/threonine binding proteins involved in
the control of several cellular events, including cell cycle
checkpoint, connective tissue remodeling, apoptosis sig-
naling, Toll-like receptor activation and TNF production
during inflammation response [47, 48]. In particular the
14-3-3 sigma induces up-regulation of differentiation,
down-regulation of cell proliferation and collagenase in-
duction as matrix metalloproteinase-1 [47, 49, 50]. Wu
et al. [12] found decreased 14-3-3 protein sigma in saliva
of subjects with generalized aggressive periodontitis,
and, analyzing the GCF, Huynh et al. [15] found 2–3
time higher level in gingivitis than in chronic
periodontitis.
Our results are congruent with an inflammatory
response oriented to defense and regeneration of in-
jured tissues. S100A9, HSPB1, LEG7 and 14-3-3 pro-
teins resulted over-expressed in periodontal pocket
tissue when compared with healthy patient analogous
tissue. A significant unbalancing in protein expres-
sion between healthy and pathological sites was re-
corded. In a previous study [6] we aimed to compare
the interproximal pocket tissue with interproximal
tissues at sites with normal probing depth in patients af-
fected from periodontal disease and HSPB1, LEG7 and
14-3-3 proteins resulted significantly under-expressed.
Also S100A9 resulted under-expressed, but not
significantly.
In all likelihood, patients have to be regarded as af-
fected by periodontal disease because a complex patho-
logic network (composed by genetic structure involving
immunology and inflammatory regulation) at the root of
periodontitis even if the periodontal disease is being
clinically burnt out [51–54].
A limited number of biomolecular studies have been
carried out on the periodontal pocket. Hence, inad-
equate data are available on the pathognomonic lesion
of the periodontal disease. Genes related to apoptosis,
antimicrobial humoral response, antigen presentation,
regulation of metabolism, signal transduction and angio-
genesis were found to be differently expressed in pa-
tients with periodontitis and healthy subjects, as found
in trascriptomic studies [55, 56]. Moreover, with the aid
of microarray technologies, cell communication path-
ways were shown to be down-regulated in periodontitis-
affected tissues, either in cell-to-cell communications at
the soft tissue level, or in cell-to-tooth signaling as a
consequence of the inflammatory status of the periodon-
tium [55, 56].
It is conjecturable that an high inflammatory back-
ground is anyway present in healthy gingival tissues of
patients with periodontal disease, and the change of the
inflammatory and immunologic processes could have a
role in periodontal damage with the hindering of the
protecting molecular network when the risk factor chal-
lenge induces the periodontal pocket.
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The identified proteins play a role in increased cell
proliferation, decrease in cell tissue differentiation,
impairing of metalloproteinases on connective tissue, or-
ganized action monocytes/macrophages (e.g. osteoclasts)
and osteoblasts or fibroblast together with enhanced
humoral and cell-mediated immunity. All these pro-
cesses are consistent with a defensive response of the or-
ganism that also aims to regenerate the lost tissue after
exogenous injury. Furthermore, the phagocytosis of op-
sonized cells, the alternative way by Toll-like receptors 2
and 4 or the T-cell activation to bacterial LPS could con-
tribute to microbiota clearance along with the presence
of chemo attractant molecules in the recruitment of im-
mune cells. During these phases, an increasing cell mi-
gration could also play an important role in the recovery
of damaged tissue as periodontal ligament or bone. It is
also to consider that HSPs, whose synthesis is increased
in response to a variety of stresses, and S100A9 play an
important role in controlling cell and tissue damage, and
in moderating inflammation and destructive immune
response. HSPB1 and S100A9 resulted significantly in-
creased, in all the tested pathological sites, while LEG7
and 14-3-3 proteins, although not expressed in normal
tissue, exhibited fluctuation in expression level in peri-
odontal lesions. These results need further studies to
understand if the lack in expression of these proteins
may worsen the tissue damage.
Conclusions
Most proteomic studies have been performed on differ-
ent biological samples but not on periodontal pocket tis-
sue that is the anatomo-pathological lesion signifying for
the clinical diagnosis of the periodontal disease. There-
fore, the periodontal pocket tissue is the only biologic
material in which proteomic analysis enables the correct
molecular assessment of this pathology. The establish-
ment of a robust proteomic expression profile database
for periodontal pathology would be highly desirable both
to understand the pathogenesis and for periodontitis
therapeutic strategies [13]. This is the first work that
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compares the proteomic content of periodontal pocket
lesions and healthy gingival tissue of healthy subjects.
The results of this study pointed out a network of pro-
teins, differently expressed in the pathological tissue
compared with the healthy one and contribute to the es-
tablishment of a proteomic expression profile database
for periodontal pathology. These data are highly desir-
able both to understand the pathogenesis and for peri-
odontitis therapeutic strategies, though further
population studies are required to correlate the prote-
omic data with clinical data, as disease progression and
aggressiveness.
Methods
Sample collection
Systemic healthy subjects, with and without periodontal
chronic disease, examined and treated in a private dental
office, were enrolled in this study, according to the
protocol described in Table 1. Italian law does not re-
quire any ethical committee authorization for clinical tri-
als performed in private dental offices, while such
authorization is required for public dental health centers
(DM 18/3/1998 published in the Official Gazette, GU n.
122 of 28-05-1998). Therefore, for the purposes of this
study all enrolled subjects signed an informed consent
form detailing the study procedures. The research was
carried out in full accordance with the ethical principles
of the WMA Helsinki Declaration [57].
Fifteen periodontally-healthy patients underwent
crown lengthening surgery, where gingiva in excess or
gingival margin asymmetries required a surgical correc-
tion [58, 59]. Periodontally-affected subjects presented at
least a shallow intrabony defect suitable for treatment by
osseous resective surgery.
Samples for microbial analysis were obtained from pa-
tients immediately before surgery, in order to exclude per-
iodontopathogenic bacteria. The samples were analyzed
by PCR-RT technique (GABA International AG, Lorrach,
Germany), to confirm the absence of Actinobacillus acti-
nomycetemcomitans, Porphyromonas gingivalis, Tanner-
ella forsythensis, Treponema denticola, Fusobacterium
nucleatum ssp, and Prevotella intermedia.
The surgery was performed in both periodontally-
healthy and -affected patients following the completion of
a preliminary cause-related treatment required for the sur-
gical approach and having reached a full-mouth plaque
score and full-mouth bleeding score lower than 20 %.
Tissue specimens of interproximal healthy tissues
were harvested in fifteen periodontally-healthy patients
(C, control) at sites with normal probing depth [58–60].
Tissue specimens of interproximal pocket-associated tis-
sue were harvested in subjects affected by chronic peri-
odontitis (T, test). The harvested tissues were immediately
frozen at −80 °C, for proteomic analyses.
Sample preparation for proteomic analysis
Tissue samples were ground in small pieces in a mortar
with liquid nitrogen and collected in tubes. Tissue lysate
was performed incubating the samples for 1 h with a
buffer containing 7 M urea, 2 M thiourea, 3 % CHAPS,
40 mM Tris pH 8.3, 1 % ampholytes pH 3–10, protease
inhibitors at room temperature. After incubation, tissues
were further disrupted with an ultrasonic homogenizer
(Sonoplus HD 2070, Bandelin electronic, Germany), and
centrifuged at 10,000 x g for 10 min at +4 °C. Supernatant
was precipitated by the addition of cold acetone (dilution
ratio 1:12 vol/vol) and incubated at −20 °C overnight.
After centrifugation at 14,000 x g for 15 min at +4 °C, the
pellet was re-suspended and the protein concentration
was determined according to the Bradford method. Three
pooled samples, both for pathological and healthy gingival
tissues, were obtained by mixing equal protein amount of
5 different subjects and were analyzed in duplicate.
2-Dimension electrophoresis
Tissue extracted proteins were separated by 2DE follow-
ing a protocol previously described [61]. Briefly, for the
first dimension, 80 μg of total proteins were loaded onto
IPG strips, 17 cm long, pH range 3–10 (ReadyStripTM,
Bio-Rad, USA). Afterwards, the second-dimension separ-
ation was carried out at 10 °C using 12 % polyacrylamide
gels. Between these two separation steps, strips were re-
duced with 1 % DTT, and later alkylated with 2.5 %
iodoacetamide in an equilibration buffer (6 M urea, 1 %
DTT, 50 mM Tris–HCl pH 8.8, 30 % glycerol, 2 % SDS).
After 2-DE, the protein spots in the gels were visualized
following a silver nitrate staining protocol, as previously
described [62]. The silver-stained gel images were ac-
quired using a GS-800 Calibrated Densitometer (Bio-
Rad, USA) and analysed with the PDQuest 2-D Image
software program, version 7.3.1 (Bio-Rad, USA).
Protein identification by LC-MS/MS analysis
Protein spots excised manually from the gels were sub-
jected to the “in-gel” tryptic digestion as previously de-
scribed [63]. Dried samples were then re-suspended in
97 % Water/3 % ACN added of 1 % formic acid (Buffer A)
and analyzed by a Nano LC-CHIP-MS system, consisting
of the Agilent 6520 ESI-Q-TOF, coupled with a 1200
Nano HPLC-Chip microfluidic device (Agilent Technolo-
gies Inc., USA). Four microliters of each sample were
loaded into the system and transported to the Chip en-
richment column (Zorbax C18, 4 mm x 5 μm i.d., Agilent
Technologies) by a capillary pump, with a loading flow
of 4 μL/min, using 95 % ACN/5 % water added of 0.1 %
formic acid (buffer B) as mobile phase. Nitrogen was
used as the nebulizing gas. A separation column
(Zorbax C18, 43 mm x 75 μm i.d., Agilent Technologies),
at flow rate of 0.4 μL/min, was used for peptide
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separation. Protein-identification peak lists were generated
using MASCOT search engine (http://mascot.cigs.unimo.
it/mascot) against the UniProt Knowledgebase database
(UniProt.org), specifying the following parameters: Homo
sapiens taxonomy, parent ion tolerance ± 20 ppm, MS/MS
error tolerance ± 0.12 Da, alkylated cysteine as fixed modi-
fication and oxidized methionine as variable modification,
and two potential missed trypsin cleavages. Proteins
that were identified with at least 2 or more significant pep-
tides sequences and with the highest score hits among
MASCOT search results. “High-scoring” corresponded
to proteins that were above the significant threshold in
Mascot searches (5 % probability of false match for each
proteins above this score).
Protein functional analysis
The protein functional analysis and classification of
identified proteins were performed using the iPROClass
integrated database (http://pir.georgetown.edu/pirwww/
dbinfo/iproclass.shtml accessed on March, 2015) for
protein annotation and GO Terms Classifications Coun-
ter (CateGOrize, http://www.animalgenome.org/bioinfo/
tools/countgo/ accessed on March, 2015) for clusteriza-
tion according to the Gene Ontology (GO) hierarchy.
Western blot analysis
For Western blotting experiments, 3 μg of gingival tissue
protein extracts were solubilized in Laemmli’s buffer 1X
and denatured for 5 min at 95 °C. Protein content was re-
solved by 12 % or 15 % SDS-PAGE and the proteins were
transferred onto a nitrocellulose membrane by electro-
blotting. Membranes were blocked at 4 °C overnight with
5 % non-fat dry milk in PBS containing 0.1 % Tween 20.
The membranes were incubated with the relevant anti-
bodies for 2 h (1:1000 dilution), washed, and incubated
with HRP coniugated Polyclonal Goat Anti-rabbit second-
ary antibody (1:2000 dilution, DakoCytomation, Denmark)
for 1 h. The proteins were visualized using WesternSure
Premium Chemiluminescent substrate (LI-COR, USA)
and C-Digit Blot scanner (LI-COR, USA) according to the
manufacturer’s instructions. Acquired images were ana-
lyzed and compared using Image Studio Software 4.0.21
(LI-COR, USA). The sources of primary antibodies were
as follows: anti-galectin 7 (ab10482), anti-HspB1 (ab1426)
and anti-14-3-3 all isoforms (ab9063) were from Abcam
(UK); anti- S100A9 (PA1-46489) was from Thermo scien-
tific (USA). β-actin (ab8227, Abcam UK) was used for
normalization of western blot analysis.
Abbreviations
2DE: Two-dimensional electrophoresis; LC-MS/MS: Liquid Chromatography-
Mass/Mass spectrometry; MW: Molecular weight; emPAI: Exponentially
modified protein abundance index; HSPB1: Heat shock protein ß-1;
LEG7: Galectin-7; 1433S: 14-3-3 Protein sigma; 1433Z: 14-3-3 protein
zeta/delta; S100A9: Protein S100-A9; GCF: Gingival Crevicular Fluid;
CHAPS: 3-[(3-Cholamidopropyl) dimethylammonio]-1-propanesulfonate;
DTT: Dithiothreitol; ACN: Acetonitrile; ESI-Q-TOF: Electrospray ionization
quadrupole time-of-flight mass; SDS-PAGE: Sodium dodecyl sulfate
polyacrylamide gel electrophoresis; HRP: Horseradish peroxidase.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
EM designed the study, performed sample preparation, western blotting
analysis and drafted the manuscript; AC carried out ESI-QTOF-MS analysis
and performed protein identification; EB and SB performed bi-dimensional
gel electrophoresis and in gel digestions; AL participated to the sample
collections; AT and DZ provided useful advices to improve the study and
revised the manuscript; PC participated in the design of the study; CB
conceived the study, participated in its design and coordination, enrolled all
subject of the study and helped to draft the manuscript. All authors read
and approved the final manuscript.
Acknowledgement
We thank Dr. Filippo Genovese (C.I.G.S., University of Modena and Reggio
Emilia) for technical assistance during LC-MS/MS analysis. We are grateful to
the “Fondazione Cassa di Risparmio di Modena, Italy” for have supported the
purchase of the ESI-Q-TOF mass spectrometer.
Author details
1Department of Diagnostic, Clinical and Public Health Medicine, University of
Modena and Reggio Emilia, Largo del Pozzo, 71-41124 Modena, Italy. 2Private
Practice, Modena, Italy. 3European Research Group on Periodontology
(ERGOPERIO), Berne, Switzerland. 4Department of Biomedical, Metabolic and
Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
5Department of Surgery, Medicine, Dentistry and Morphological Sciences
with Transplant Surgery, Oncology and Regenerative Medicine Relevance,
University of Modena and Reggio Emilia, Modena, Italy.
Received: 28 September 2015 Accepted: 18 December 2015
References
1. Bertoldi C, Bencivenni D, Lucchi A, Consolo U. Augmentation of keratinized
gingiva through bilaminar connective tissue grafts: a comparison between
two techniques. Minerva Stomatol. 2007;56:3–20.
2. Tripodo C, Di Bernardo A, Ternullo MP, Guarnotta C, Porcasi R, Ingrao S, et
al. CD146(+) bone marrow osteoprogenitors increase in the advanced
stages of primary myelofibrosis. Haematologica. 2009;94:127–30.
3. Flemmig TF. Periodontitis. Ann Periodontol. 1999;4:32–8.
4. Socransky SS, Haffajee AD. The nature of periodontal diseases. Ann
Periodontol. 1997;2:3–10.
5. Bertoldi C, Pellacani C, Lalla M, Consolo U, Pinti M, Cortellini P, et al. Herpes
Simplex I virus impairs regenerative outcomes of periodontal regenerative
therapy in intrabony defects: a pilot study. J Clin Periodontol. 2012;39:385–92.
6. Bertoldi C, Bellei E, Pellacani C, Ferrari D, Lucchi A, Cuoghi A, et al. Non-
bacterial protein expression in periodontal pockets by proteome analysis.
J Clin Periodontol. 2013;40:573–82.
7. Tonetti MS, Claffey N. Advances in the progression of periodontitis and
proposal of definitions of a periodontitis case and disease progression for
use in risk factor research. Group C consensus report of the 5th European
Workshop in Periodontology. J Clin Periodontol. 2005;32 Suppl 6:210–3.
8. Page RC, Eke PI. Case definitions for use in population-based surveillance of
periodontitis. J Periodontol. 2007;78:1387–99.
9. Huang R-Y, Lu S-H, Su K-W, Chen J-K, Fang W-H, Liao W-N, et al. Diacerein: a
potential therapeutic drug for periodontal disease. Med Hypotheses.
2012;79:165–7.
10. Kornman KS. Mapping the pathogenesis of periodontitis: a new look.
J Periodontol. 2008;79:1560–8.
11. Gonçalves LDR, Soares MR, Nogueira FCS, Garcia C, Camisasca DR, Domont
G, et al. Comparative proteomic analysis of whole saliva from chronic
periodontitis patients. J Proteomics. 2010;73:1334–41.
12. Wu Y, Shu R, Luo L-J, Ge L-H, Xie Y-F. Initial comparison of proteomic
profiles of whole unstimulated saliva obtained from generalized aggressive
periodontitis patients and healthy control subjects. J Periodontal Res.
2009;44:636–44.
Monari et al. Proteome Science  (2015) 13:33 Page 9 of 11
13. Gorr S-U, Abdolhosseini M. Antimicrobial peptides and periodontal disease.
J Clin Periodontol. 2011;38 Suppl 1:126–41.
14. Jönsson D, Ramberg P, Demmer RT, Kebschull M, Dahlén G, Papapanou PN.
Gingival tissue transcriptomes in experimental gingivitis. J Clin Periodontol.
2011;38:599–611.
15. Huynh AHS, Veith PD, McGregor NR, Adams GG, Chen D, Reynolds EC, et al.
Gingival crevicular fluid proteomes in health, gingivitis and chronic
periodontitis. J Periodontal Res. 2015;50:637–49.
16. Yokoyama T, Kobayashi T, Yamamoto K, Yamagata A, Oofusa K, Yoshie H.
Proteomic profiling of human neutrophils in relation to immunoglobulin G
Fc receptor IIIb polymorphism. J Periodontal Res. 2010;45:780–7.
17. Mizuno N, Niitani M, Shiba H, Iwata T, Hayashi I, Kawaguchi H, et al.
Proteome analysis of proteins related to aggressive periodontitis
combined with neutrophil chemotaxis dysfunction. J Clin Periodontol.
2011;38:310–7.
18. Yokoyama T, Kobayashi T, Ito S, Yamagata A, Ishida K, Okada M, et al.
Comparative analysis of serum proteins in relation to rheumatoid arthritis
and chronic periodontitis. J Periodontol. 2014;85:103–12.
19. Pham TK, Roy S, Noirel J, Douglas I, Wright PC, Stafford GP. A quantitative
proteomic analysis of biofilm adaptation by the periodontal pathogen
Tannerella forsythia. Proteomics. 2010;10:3130–41.
20. AlMoharib HS, AlMubarak A, AlRowis R, Geevarghese A, Preethanath RS, Anil
S. Oral fluid based biomarkers in periodontal disease: part 1. Saliva. J Int oral
Heal. 2014;6:95–103.
21. Trindade F, Oppenheim FG, Helmerhorst EJ, Amado F, Gomes PS, Vitorino R.
Uncovering the molecular networks in periodontitis. Proteomics Clin Appl.
2014;8:748–61.
22. Guzman YA, Sakellari D, Arsenakis M, Floudas CA. Proteomics for the
discovery of biomarkers and diagnosis of periodontitis: a critical review.
Expert Rev Proteomics. 2014;11:31–41.
23. Gupta A, Govila V, Saini A. Proteomics - The research frontier in
periodontics. J Oral Biol Craniofacial Res. 2015;5:46–52.
24. Kornman KS, Crane A, Wang HY, di Giovine FS, Newman MG, Pirk FW, et al.
The interleukin-1 genotype as a severity factor in adult periodontal disease.
J Clin Periodontol. 1997;24:72–7.
25. Masamatti S, Kumar A, Mehta D, Bhat K, Baron TK. Evaluation of
interleukin -1B (+3954) gene polymorphism in patients with chronic
and aggressive periodontitis: a genetic association study. Contemp Clin
Dent. 2012;3:144.
26. Yang W, Jia Y, Wu H. Four tumor necrosis factor alpha genes
polymorphisms and periodontitis risk in a Chinese population. Hum
Immunol. 2013;74:1684–7.
27. Marenholz I, Heizmann CW, Fritz G. S100 proteins in mouse and man: from
evolution to function and pathology (including an update of the
nomenclature). Biochem Biophys Res Commun. 2004;322:1111–22.
28. Goyette J, Geczy CL. Inflammation-associated S100 proteins: new
mechanisms that regulate function. Amino Acids. 2011;41:821–42.
29. Srikrishna G. S100A8 and S100A9: new insights into their roles in
malignancy. J Innate Immun. 2012;4:31–40.
30. Kido J, Bando M, Hiroshima Y, Iwasaka H, Yamada K, Ohgami N, et al.
Analysis of proteins in human gingival crevicular fluid by mass
spectrometry. J Periodontal Res. 2012;47:488–99.
31. Kojima T, Andersen E, Sanchez JC, Wilkins MR, Hochstrasser DF, Pralong WF,
et al. Human gingival crevicular fluid contains MRP8 (S100A8) and MRP14
(S100A9), two calcium-binding proteins of the S100 family. J Dent Res.
2000;79:740–7.
32. Andersen E, Dessaix IM, Perneger T, Mombelli A. Myeloid-related protein
(MRP8/14) expression in gingival crevice fluid in periodontal health and
disease and after treatment. J Periodontal Res. 2010;45:458–63.
33. Ellias MF, Zainal Ariffin SH, Karsani SA, Abdul Rahman M, Senafi S, Megat
Abdul Wahab R. Proteomic analysis of saliva identifies potential biomarkers
for orthodontic tooth movement. Sci World J. 2012;2012:1–6.
34. Zheng Y, Hou J, Peng L, Zhang X, Jia L, Wang X, et al. The Pro-Apoptotic
and Pro-Inflammatory Effects of Calprotectin on Human Periodontal
Ligament Cells. Glogauer M, editor. PLoS One. 2014;9:e110421.
35. Leonardi R, Villari L, Caltabiano M, Travali S. Heat shock protein 27
expression in the epithelium of periapical lesions. J Endod. 2001;27:89–92.
36. Park J-H, Yoon J-H, Lim Y-S, Hwang H-K, Kim S-A, Ahn S-G, et al.
TAT-Hsp27 promotes adhesion and migration of murine dental
papilla-derived MDPC-23 cells through beta1 integrin-mediated
signaling. Int J Mol Med. 2010;26:373–8.
37. Mitsuhashi M, Yamaguchi M, Kojima T, Nakajima R, Kasai K. Effects of HSP70
on the compression force-induced TNF-α and RANKL expression in human
periodontal ligament cells. Inflamm Res. 2011;60:187–94.
38. Sreedharan R, Riordan M, Thullin G, Van Why S, Siegel NJ, Kashgarian M. The
maximal cytoprotective function of the heat shock protein 27 is dependent
on heat shock protein 70. Biochim Biophys Acta. 2011;1813:129–35.
39. Koromantzos PA, Makrilakis K, Dereka X, Offenbacher S, Katsilambros N,
Vrotsos IA, et al. Effect of non-surgical periodontal therapy on C-Reactive
Protein, Oxidative Stress, and Matrix Metalloproteinase (MMP)-9 and MMP-2
levels in patients with type 2 diabetes: a randomized controlled study.
J Periodontol. 2012;83:3–10.
40. Kwon S-M, Kim S-A, Yoon J-H, Ahn S-G. Transforming growth factor beta1-
induced heat shock protein 27 activation promotes migration of mouse
dental papilla-derived MDPC-23 cells. J Endod. 2010;36:1332–5.
41. Chung E, Rylander MN. Response of preosteoblasts to thermal stress conditioning
and osteoinductive growth factors. Cell Stress Chaperones. 2012;17:203–14.
42. Kuwabara I, Kuwabara Y, Yang R-Y, Schuler M, Green DR, Zuraw BL,
et al. Galectin-7 (PIG1) exhibits pro-apoptotic function through JNK
activation and mitochondrial cytochrome c release. J Biol Chem. 2002;
277:3487–97.
43. Saussez S, Kiss R. Galectin-7. Cell Mol Life Sci. 2006;63:686–97.
44. Polla BS, Cossarizza A. Stress proteins in inflammation. EXS. 1996;77:375–91.
45. Leonardi R, Pannone G, Magro G, Kudo Y, Takata T, Lo ML. Differential
expression of heat shock protein 27 in normal oral mucosa, oral epithelial
dysplasia and squamous cell carcinoma. Oncol Rep. 2002;9:261–6.
46. Alford KA, Glennie S, Turrell BR, Rawlinson L, Saklatvala J, Dean JLE. Heat
shock protein 27 functions in inflammatory gene expression and
transforming growth factor-beta-activated kinase-1 (TAK1)-mediated
signaling. J Biol Chem. 2007;282:6232–41.
47. Asdaghi N, Kilani RT, Hosseini-Tabatabaei A, Odemuyiwa SO, Hackett T-L,
Knight DA, et al. Extracellular 14-3-3 from human lung epithelial cells
enhances MMP-1 expression. Mol. Cell. Biochem. 2012;360:261–70.
48. Ben-Addi A, Mambole-Dema A, Brender C, Martin SR, Janzen J, Kjaer S, et al.
IκB kinase-induced interaction of TPL-2 kinase with 14-3-3 is essential for
Toll-like receptor activation of ERK-1 and −2 MAP kinases. Proc Natl Acad
Sci U S A. 2014;111:E2394–403.
49. Westfall MD, Mays DJ, Sniezek JC, Pietenpol JA. The Np63 Phosphoprotein
Binds the p21 and 14-3-3 Promoters In Vivo and Has Transcriptional
Repressor Activity That Is Reduced by Hay-Wells Syndrome-Derived
Mutations. Mol Cell Biol. 2003;23:2264–76.
50. Oh J-E, Jang DH, Kim H, Kang HK, Chung C-P, Park WH, et al.
Alpha3Beta1 integrin promotes cell survival via multiple interactions
between 14-3-3 isoforms and proapoptotic proteins. Exp Cell Res. 2009;
315:3187–200.
51. Dowsett SA, Archila L, Foroud T, Koller D, Eckert GJ, Kowolik MJ. The effect of
shared genetic and environmental factors on periodontal disease parameters
in untreated adult siblings in Guatemala. J Periodontol. 2002;73:1160–8.
52. Kinane DF, Lappin DF. Immune processes in periodontal disease: a review.
Ann Periodontol. 2002;7:62–71.
53. Dasanayake AP. Periodontal disease is related to local and systemic
mediators of inflammation. J Evid Based Dent Pract. 2010;10:246–7.
54. Taba M, de Souza SLS, Mariguela VC. Periodontal disease: a genetic
perspective. Braz Oral Res. 2012;26 Suppl 1:32–8.
55. Demmer RT, Behle JH, Wolf DL, Handfield M, Kebschull M, Celenti R, et al.
Transcriptomes in healthy and diseased gingival tissues. J Periodontol.
2008;79:2112–24.
56. Abe D, Kubota T, Morozumi T, Shimizu T, Nakasone N, Itagaki M, et al.
Altered gene expression in leukocyte transendothelial migration and cell
communication pathways in periodontitis-affected gingival tissues.
J Periodontal Res. 2011;46:345–53.
57. Puri KS, Suresh KR, Gogtay NJ, Thatte UM. Declaration of Helsinki, 2008:
implications for stakeholders in research. J Postgrad Med. 2009;55:131–4.
58. Pontoriero R, Carnevale G. Surgical crown lengthening: a 12-month clinical
wound healing study. J Periodontol. 2001;72:841–8.
59. Ribeiro FV, Hirata DY, Reis AF, Santos VR, Miranda TS, Faveri M, et al.
Open-flap versus flapless esthetic crown lengthening: 12-month clinical
outcomes of a randomized controlled clinical trial. J Periodontol. 2014;
85:536–44.
60. Nethravathy R, Vinoth SK, Thomas AV. Three different surgical techniques
of crown lengthening: a comparative study. J Pharm Bioallied Sci.
2013;5:S14–6.
Monari et al. Proteome Science  (2015) 13:33 Page 10 of 11
61. Bellei E, Monari E, Bergamini S, Ozben T, Tomasi A. Optimizing protein
recovery yield from serum samples treated with beads technology.
Electrophoresis. 2011;32:1414–21.
62. Bellei E, Rossi E, Lucchi L, Uggeri S, Albertazzi A, Tomasi A, et al. Proteomic
analysis of early urinary biomarkers of renal changes in type 2 diabetic
patients. Proteomics Clin Appl. 2008;2:478–91.
63. Bellei E, Bergamini S, Monari E, Fantoni LI, Cuoghi A, Ozben T, et al. High-
abundance proteins depletion for serum proteomic analysis: concomitant
removal of non-targeted proteins. Amino Acids. 2011;40:145–56.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Monari et al. Proteome Science  (2015) 13:33 Page 11 of 11
